New perspectives on the role of cardiac magnetic resonance imaging to evaluate myocardial salvage and myocardial hemorrhage after acute reperfused ST-elevation myocardial infarction

Expert Review of Cardiovascular Therapy

Volumn 14, Issue 7, 2016, Pages 843-854

  Mangion, Kenneth ^a,b   Corcoran, David ^a,b   Carrick, David ^a,b   Berry, Colin ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GOLDEN JUBILEE NATIONAL HOSPITAL   (United Kingdom)

Author keywords

magnetic resonance imaging; microvascular dysfunction; myocardial hemorrhage; prognosis; remodeling; ST elevation myocardial infarction

Indexed keywords

BLEEDING; BLOOD VESSEL INJURY; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL TRIAL (TOPIC); EDEMA; GRAFT SALVAGE; HEART INFARCTION SIZE; HUMAN; INTRAMYOCARDIAL HEMORRHAGE; MYOCARDIAL DISEASE; NONHUMAN; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; CARDIAC MUSCLE; DIAGNOSTIC IMAGING; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; PROGNOSIS; TIME FACTOR;

BIOLOGICAL MARKER;

BIOMARKERS; EDEMA; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL REPERFUSION; MYOCARDIUM; PROGNOSIS; ST ELEVATION MYOCARDIAL INFARCTION; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 84975138677     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.2016.1173544     Document Type: Review

References (105)

1. Authors/Task Force Members, P.G.Steg, S.K.James, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J. 2012 Oct 2;33(20):2569–2619.
2. J.P.Greenwood, J.F.Younger, J.P.Ridgway, et al. Safety and diagnostic accuracy of stress cardiac magnetic resonance imaging vs exercise tolerance testing early after acute ST elevation myocardial infarction. Heart. 2007 Nov;93(11):1363–1368.
3. S.Plein, J.P.Greenwood, J.P.Ridgway, et al. Assessment of non-ST-segment elevation acute coronary syndromes with cardiac magnetic resonance imaging. J Am Coll Cardiol. 2004 Dec 7;44(11):2173–2181.
4. M.G.Friedrich Tissue characterization of acute myocardial infarction and myocarditis by cardiac magnetic resonance. JACC Cardiovasc Imaging. 2008 Sep 1;1(5):652–662.
5. K.A.Reimer, R.B.Jennings. The ‘wavefront phenomenon’ of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Investig J Tech Methods Pathol. 1979 Jun;40(6):633–644.• The original description of the wavefront phenomenon.
6. C.Berry, P.Kellman, C.Mancini, et al. Magnetic resonance imaging delineates the ischemic area-at-risk and myocardial salvage in patients with acute myocardial infarction. Circ Cardiovasc Imaging. 2010 Sep 1;3(5):527–535.• These investigators assessed the feasibility of measuring the area-at-risk in 50 patients using bright-blood T2-weighted sequences.
7. D.Garcia-Dorado, J.Oliveras, J.Gili, et al. Analysis of myocardial oedema by magnetic resonance imaging early after coronary artery occlusion with or without reperfusion. Cardiovasc Res. 1993 Aug 1;27(8):1462–1469.• Paper describing the first animal experiments to investigate myocardial edema using CMR.
8. L.M.Boxt, D.Hsu, J.Katz, et al. Estimation of myocardial water content using transverse relaxation time from dual spin-echo magnetic resonance imaging. Magn Reson Imaging. 1993;11(3):375–383.
9. A.H.Aletras, G.S.Tilak, A.Natanzon, et al. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation. 2006 Apr 18;113(15):1865–1870.
10. G.S.Tilak, L.-Y.Hsu, R.F.Hoyt, et al. In vivo T2-weighted magnetic resonance imaging can accurately determine the ischemic area at risk for 2-day-old nonreperfused myocardial infarction. Invest Radiol. 2008 Jan;43(1):7–15.
11. D.Garcia-Dorado, P.Théroux, J.Solares, et al. Determinants of hemorrhagic infarcts. Histologic observations from experiments involving coronary occlusion, coronary reperfusion, and reocclusion. Am J Pathol. 1990 Aug;137(2):301–311.
12. A.H.Aletras, P.Kellman, J.A.Derbyshire, et al. ACUT2E TSE-SSFP: A hybrid method for T2-weighted imaging of edema in the heart. Magn Reson Med. 2008 Feb 1;59(2):229–235.
13. D.P.O’Regan, R.Ahmed, C.Neuwirth, et al. Cardiac MRI of myocardial salvage at the peri-infarct border zones after primary coronary intervention. Am J Physiol Heart Circ Physiol. 2009 Jul;297(1):H340–H346.
14. P.Kellman, A.H.Aletras, C.Mancini, et al. T2-prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared to turbo spin echo. Magn Reson Med. 2007 May;57(5):891–897.
15. S.Giri, Y.-C.Chung, A.Merchant, et al. T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson. 2009 Dec 30;11(1):56.
16. D.Verhaert, P.Thavendiranathan, S.Giri, et al. Direct T2 quantification of myocardial edema in acute ischemic injury. JACC Cardiovasc Imaging. 2011 Mar 1;4(3):269–278.
17. W.B.Wince, R.J.Kim. Molecular imaging: T2-weighted CMR of the area at risk–a risky business? Nat Rev Cardiol. 2010 Oct;7(10):547–549.
18. R.Y.Kwong, A.Farzaneh-Far. Measuring myocardial scar by CMR. JACC Cardiovasc Imaging. 2011 Feb;4(2):157–160.
19. M.Salerno, C.M.Kramer. Advances in parametric mapping with CMR imaging. JACC Cardiovasc Imaging. 2013 Jul 1;6(7):806–822.
20. A.J.Buda, A.M.Aisen, J.E.Juni, et al. Detection and sizing of myocardial ischemia and infarction by nuclear magnetic resonance imaging in the canine heart. Am Heart J. 1985 Dec;110(6):1284–1290.
21. J.W.Goldfarb, S.Arnold, J.Han. Recent myocardial infarction: assessment with unenhanced T1-weighted MR imaging. Radiology. 2007 Oct 1;245(1):245–250.
22. P.Kellman, M.S.Hansen. T1-mapping in the heart: accuracy and precision. J Cardiovasc Magn Reson. 2014;16:2.
23. M.Ugander, P.S.Bagi, A.J.Oki, et al. Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. JACC Cardiovasc Imaging. 2012 Jun;5(6):596–603.
24. D.R.Messroghli, A.Greiser, M.Fröhlich, et al. Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart. J Magn Reson Imaging JMRI. 2007 Oct;26(4):1081–1086.
25. E.Dall’Armellina, S.K.Piechnik, V.M.Ferreira, et al. Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction. J Cardiovasc Magn Reson. 2012 Feb 6;14(1):15.
26. S.K.Piechnik, V.M.Ferreira, E.Dall’Armellina, et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson. 2010 Nov 19;12(1):69.
27. H.Bulluck, S.K.White, S.Rosmini, et al. T1 mapping and T2 mapping at 3T for quantifying the area-at-risk in reperfused STEMI patients. J Cardiovasc Magn Reson. 2015 Aug 12;17(1):73.• The authors assess the area-at-risk using both T1 and T2 parametric maps and conclude that the area-at-risk assessed by both techniques is reproducible.
28. D.L.Johnston, T.J.Brady, A.V.Ratner, et al. Assessment of myocardial ischemia with proton magnetic resonance: effects of a three hour coronary occlusion with and without reperfusion. Circulation. 1985;71(3):595–601.
29. D.D.Miller, D.L.Johnston, D.Dragotakes, et al. Effect of hyperosmotic mannitol on magnetic resonance relaxation parameters in reperfused canine myocardial infarction. Magn Reson Imaging. 1989 Feb;7(1):79–88.
30. T.Ryan, R.D.Tarver, J.L.Duerk, et al. Distinguishing viable from infarcted myocardium after experimental ischemia and reperfusion by using nuclear magnetic resonance imaging. J Am Coll Cardiol. 1990 May;15(6):1355–1364.
31. H.W.Kim, L.Van Assche, R.B.Jennings, et al. Relationship of T2-weighted mri myocardial hyperintensity and the ischemic area-at-riskNovelty and significance. Circ Res. 2015 Jul 17;117(3):254–265.
32. C.Basso, G.Thiene. The pathophysiology of myocardial reperfusion: a pathologist’s perspective. Heart. 2006 Nov;92(11):1559–1562.
33. C.S.Lotan, S.K.Miller, G.B.Cranney, et al. The effect of postinfarction intramyocardial hemorrhage on transverse relaxation time. Magn Reson Med. 1992 Feb;23(2):346–355.
34. Y.Mikami, H.Sakuma, M.Nagata, et al. Relation between signal intensity on t2-weighted mr images and presence of microvascular obstruction in patients with acute myocardial infarction. Am J Roentgenol. 2009 Oct 1;193(4):W321–6.
35. P.Croisille, H.W.Kim, R.J.Kim. Controversies in Cardiovascular MR Imaging: T2-weighted Imaging Should Not Be Used to Delineate the Area at Risk in Ischemic Myocardial Injury. Radiology. 2012 Oct 1;265(1):12–22.
36. S.Hammer-Hansen, M.Ugander, L.-Y.Hsu, et al. Distinction of salvaged and infarcted myocardium within the ischaemic area-at-risk with T2 mapping. Eur Heart J Cardiovasc Imaging. 2014 Sep;15(9):1048–1053.
37. I.Eitel, S.Desch, G.Fuernau, et al. Prognostic Significance and Determinants of Myocardial Salvage Assessed by Cardiovascular Magnetic Resonance in Acute Reperfused Myocardial Infarction. J Am Coll Cardiol. 2010 Jun;55(22):2470–2479.
38. H.Bulluck, S.K.White, G.M.Fröhlich, et al. Quantifying the area at risk in reperfused ST-segment–elevation myocardial infarction patients using hybrid cardiac positron emission tomography–magnetic resonance imaging. Circ Cardiovasc Imaging. 2016 Mar 1;9(3):e003900.
39. R.Fernández-Jiménez, J.Sánchez-González, J.Agüero, et al. Myocardial Edema After Ischemia/Reperfusion Is Not Stable and Follows a Bimodal Pattern. J Am Coll Cardiol. 2015 Feb;65(4):315–323.
40. R.Fernández-Jiménez, J.García-Prieto, J.Sánchez-González, et al. Pathophysiology Underlying the Bimodal Edema Phenomenon After Myocardial Ischemia/Reperfusion. J Am Coll Cardiol. 2015 Aug 18;66(7):816–828.
41. A.R.Payne, C.Berry, P.Kellman, et al. Bright-blood T2-weighted MRI has high diagnostic accuracy for myocardial hemorrhage in myocardial infarction A preclinical validation study in swine. Circ Cardiovasc Imaging. 2011 Nov 1;4(6):738–745.
42. D.Carrick, C.Haig, N.Ahmed, et al. Myocardial hemorrhage after acute reperfused ST-segment–elevation myocardial infarction relation to microvascular obstruction and prognostic significance. Circ Cardiovasc Imaging. 2016 Jan 1;9(1):e004148.
43. E.Dall’Armellina, N.Karia, A.C.Lindsay, et al. Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index. Circ Cardiovasc Imaging. 2011 May;4(3):228–236.
44. A.R.Payne, M.Casey, J.McClure, et al. Bright-blood T2-weighted MRI has higher diagnostic accuracy than dark-blood short tau inversion recovery MRI for detection of acute myocardial infarction and for assessment of the ischemic area at risk and myocardial salvage. Circ Cardiovasc Imaging. 2011 May;4(3):210–219.
45. D.Carrick, C.Berry. Prognostic importance of myocardial infarct characteristics. Eur Heart J Cardiovasc Imaging. 2013 Apr;14(4):313–315.
46. K.C.Wu, E.A.Zerhouni, R.M.Judd, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998 Mar 3;97(8):765–772.
47. M.Van Kranenburg, M.Magro, H.Thiele, et al. Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients. JACC Cardiovasc Imaging. 2014 Sep;7(9):930–939.
48. J.Ganame, G.Messalli, S.Dymarkowski, et al. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. Eur Heart J. 2009 Jun;30(12):1440–1449.
49. S.C.A.M.Bekkers, M.W.Smulders, V.L.Passos, et al. Clinical implications of microvascular obstruction and intramyocardial haemorrhage in acute myocardial infarction using cardiovascular magnetic resonance imaging. Eur Radiol. 2010 Nov;20(11):2572–2578.
50. D.P.O’Regan, B.Ariff, C.Neuwirth, et al. Assessment of severe reperfusion injury with T2* cardiac MRI in patients with acute myocardial infarction. Heart Br Card Soc. 2010 Dec;96(23):1885–1891.
51. I.Eitel, K.Kubusch, O.Strohm, et al. Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation-myocardial infarction. Circ Cardiovasc Imaging. 2011 Jul;4(4):354–362.
52. N.Amabile, A.Jacquier, A.Shuhab, et al. Incidence, predictors, and prognostic value of intramyocardial hemorrhage lesions in ST elevation myocardial infarction. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv. 2012 Jun 1;79(7):1101–1108.
53. O.Husser, J.V.Monmeneu, J.Sanchis, et al. Cardiovascular magnetic resonance-derived intramyocardial hemorrhage after STEMI: influence on long-term prognosis, adverse left ventricular remodeling and relationship with microvascular obstruction. Int J Cardiol. 2013 Sep 1;167(5):2047–2054.
54. M.I.Zia, N.R.Ghugre, K.A.Connelly, et al. Characterizing myocardial edema and hemorrhage using quantitative T2 and T2* mapping at multiple time intervals post ST-segment elevation myocardial infarction. Circ Cardiovasc Imaging. 2012 Sep 1;5(5):566–572.
55. D.Kandler, C.Lücke, M.Grothoff, et al. The relation between hypointense core, microvascular obstruction and intramyocardial haemorrhage in acute reperfused myocardial infarction assessed by cardiac magnetic resonance imaging. Eur Radiol. 2014 Dec;24(12):3277–3288.• The investigators demonstrate that in STEMI patients a hypointense core on T2* was also present on T2-weighted imaging but not vice versa.
56. R.B.Driesen, J.Zalewski, N.V.Driessche, et al. Histological correlate of a cardiac magnetic resonance imaged microvascular obstruction in a porcine model of ischemia–reperfusion. Cardiovasc Pathol. 2012 May;21(3):129–131.
57. R.A.Kloner, C.E.Ganote, R.B.Jennings. The ‘no-reflow’ phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974 Dec;54(6):1496–1508.
58. L.H.Manciet, D.C.Poole, P.F.McDonagh, et al. Microvascular compression during myocardial ischemia: mechanistic basis for no-reflow phenomenon. Am J Physiol. 1994 Apr;266(4 Pt 2):H1541–H1550.
59. P.Kleinbongard, D.Böse, T.Baars, et al. Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation. Circ Res. 2011 Feb 4;108(3):344–352.
60. W.G.Bradley. MR appearance of hemorrhage in the brain. Radiology. 1993 Oct;189(1):15–26.
61. L.Galiuto. Optimal therapeutic strategies in the setting of post-infarct no reflow: the need for a pathogenetic classification. Heart Br Card Soc. 2004 Feb;90(2):123–125.
62. R.F.Wilson, D.D.Laxson, J.R.Lesser, et al. Intense microvascular constriction after angioplasty of acute thrombotic coronary arterial lesions. Lancet Lond Engl. 1989 Apr 15;1(8642):807–811.
63. K.A.Reimer, J.E.Lowe, M.M.Rasmussen, et al. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation. 1977 Nov;56(5):786–794.
64. L.F.H.J.Robbers, E.S.Eerenberg, P.F.A.Teunissen, et al. Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage. Eur Heart J. 2013 Aug;34(30):2346–2353.
65. A.Kali, R.L.Q.Tang, A.Kumar, et al. Detection of acute reperfusion myocardial hemorrhage with cardiac MR imaging: T2 versus T2. Radiology. 2013 Nov;269(2):387–395.• The authors compared T2- versus T2*-weighted imaging for the detection of IMH in both humans and canines, demonstrating T2* was superior.
66. K.C.Wu. CMR of microvascular obstruction and hemorrhage in myocardial infarction. J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson. 2012;14:68.
67. A.M.Beek, R.Nijveldt, A.C.Van Rossum. Intramyocardial hemorrhage and microvascular obstruction after primary percutaneous coronary intervention. Int J Cardiovasc Imaging. 2010 Jan;26(1):49–55.
68. A.Kumar, J.D.Green, J.M.Sykes, et al. Detection and quantification of myocardial reperfusion hemorrhage using T2*-weighted CMR. JACC Cardiovasc Imaging. 2011 Dec;4(12):1274–1283.
69. A.Kidambi, A.N.Mather, M.Motwani, et al. The effect of microvascular obstruction and intramyocardial hemorrhage on contractile recovery in reperfused myocardial infarction: insights from cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2013 Jun 27;15(1):58.
70. A.N.Mather, T.A.Fairbairn, S.G.Ball, et al. Reperfusion haemorrhage as determined by cardiovascular MRI is a predictor of adverse left ventricular remodelling and markers of late arrhythmic risk. Heart Br Card Soc. 2011 Mar;97(6):453–459.
71. C.Basso, F.Corbetti, C.Silva, et al. Morphologic validation of reperfused hemorrhagic myocardial infarction by cardiovascular magnetic resonance. Am J Cardiol. 2007 Oct 15;100(8):1322–1327.
72. C.Cannan, I.Eitel, J.Hare, et al. Hemorrhage in the Myocardium Following Infarction. JACC Cardiovasc Imaging. 2010 Jun 1;3(6):665–668.
73. C.Jackowski, A.Christe, M.Sonnenschein, et al. Postmortem unenhanced magnetic resonance imaging of myocardial infarction in correlation to histological infarction age characterization. Eur Heart J. 2006 Oct;27(20):2459–2467.
74. M.Westwood, L.J.Anderson, D.N.Firmin, et al. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging JMRI. 2003 Jul;18(1):33–39.
75. J.W.Goldfarb, U.Hasan, W.Zhao, et al. Magnetic resonance susceptibility weighted phase imaging for the assessment of reperfusion intramyocardial hemorrhage. Magn Reson Med. 2014 Mar;71(3):1210–1220.
76. S.F.Pedersen, S.A.Thrysøe, M.P.Robich, et al. Assessment of intramyocardial hemorrhage by T1-weighted cardiovascular magnetic resonance in reperfused acute myocardial infarction. J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson. 2012;14:59.
77. J.J.Brown, T.M.Peterson, R.A.Slutsky. Regional myocardial blood flow, edema formation, and magnetic relaxation times during acute myocardial ischemia in the canine. Invest Radiol. 1985 Aug;20(5):465–471.
78. D.L.Johnston, S.Homma, P.Liu, et al. Serial changes in nuclear magnetic resonance relaxation times after myocardial infarction in the rabbit: relationship to water content, severity of ischemia, and histopathology over a six-month period. Magn Reson Med. 1988 Dec;8(4):363–379.
79. S.Dymarkowski, Y.Ni, Y.Miao, et al. Value of t2-weighted magnetic resonance imaging early after myocardial infarction in dogs: comparison with bis-gadolinium-mesoporphyrin enhanced T1-weighted magnetic resonance imaging and functional data from cine magnetic resonance imaging. Invest Radiol. 2002 Feb;37(2):77–85.
80. A.Bouchard, R.C.Reeves, G.Cranney, et al. Assessment of myocardial infarct size by means of T2-weighted 1H nuclear magnetic resonance imaging. Am Heart J. 1989 Feb;117(2):281–289.
81. S.I.Choi, C.Z.Jiang, K.H.Lim, et al. Application of breath-hold T2-weighted, first-pass perfusion and gadolinium-enhanced T1-weighted MR imaging for assessment of myocardial viability in a pig model. J Magn Reson Imaging JMRI. 2000 May;11(5):476–480.
82. J.C.Nilsson, G.Nielsen, B.A.Groenning, et al. Sustained postinfarction myocardial oedema in humans visualised by magnetic resonance imaging. Heart Br Card Soc. 2001 Jun;85(6):639–642.
83. H.Abdel-Aty, A.Zagrosek, J.Schulz-Menger, et al. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation. 2004 May 25;109(20):2411–2416.
84. H.Abdel-Aty, O.Simonetti, M.G.Friedrich. T2-weighted cardiovascular magnetic resonance imaging. J Magn Reson Imaging JMRI. 2007 Sep;26(3):452–459.
85. A.E.Arai. Using magnetic resonance imaging to characterize recent myocardial injury: utility in acute coronary syndrome and other clinical scenarios. Circulation. 2008 Aug 19;118(8):795–796.
86. D.Pennell. Myocardial salvage: retrospection, resolution, and radio waves. Circulation. 2006 Apr 18;113(15):1821–1823.
87. J.Tufvesson, M.Carlsson, A.H.Aletras, et al. Automatic segmentation of myocardium at risk from contrast enhanced SSFP CMR: validation against expert readers and SPECT. BMC Med Imaging. 2016;16(1):19.
88. D.Atar, H.Arheden, A.Berdeaux, et al. Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results. Eur Heart J. 2015 Jan 7;36(2):112–119.
89. H.Engblom, E.Heiberg, D.Erlinge, et al. Sample size in clinical cardioprotection trials using myocardial salvage index, infarct size, or biochemical markers as endpoint. J Am Heart Assoc. 2016;5(3):47–55.
90. B.Langhans, J.Nadjiri, C.Jähnichen, et al. Reproducibility of area at risk assessment in acute myocardial infarction by T1- and T2-mapping sequences in cardiac magnetic resonance imaging in comparison to Tc99m-sestamibi SPECT. Int J Cardiovasc Imaging. 2014 Oct;30(7):1357–1363.
91. A.N.Mather, T.A.Fairbairn, N.J.Artis, et al. Timing of cardiovascular MR imaging after acute myocardial infarction: effect on estimates of infarct characteristics and prediction of late ventricular remodeling. Radiology. 2011 Oct;261(1):116–126.
92. D.Carrick, C.Haig, S.Rauhalammi, et al. Pathophysiology of LV remodeling in survivors of STEMI. Jacc Cardiovasc Imaging. 2015 Jul;8(7):779–789.
93. D.Carrick, C.Haig, S.M.Rauhalammi, et al. Prognostic significance of infarct core pathology in ST-elevation myocardial infarction survivors revealed by quantitative T2-weighted cardiac magnetic resonance. J Cardiovasc Magn Reson. 2015 Feb 3;17(Suppl 1):O54.
94. J.Layland, S.M.Rauhalammi, D.Carrick, et al. T1 and T2 Mapping have a higher diagnostic accuracy for the ischaemic area-at-risk in NSTEMI patients compared with dark blood imaging. J Cardiovasc Magn Reson. 2014 Jan 16;16(Suppl 1):M4.
95. S.Moral, J.F.Rodríguez-Palomares, M.Descalzo, et al. Quantification of myocardial area at risk: validation of coronary angiographic scores with cardiovascular magnetic resonance methods. Rev Esp Cardiol. 2012 Jan 11;65(11):1010–1017.
96. J.Wright, T.Adriaenssens, S.Dymarkowski, et al. Quantification of myocardial area at risk with T2-weighted CMR: comparison with contrast-enhanced CMR and coronary angiography. JACC Cardiovasc Imaging. 2009 Jul;2(7):825–831.
97. P.P.Buszman, W.Wojakowski, K.Milewski, et al. Controlled reperfusion with intravenous bivalirudin and intracoronary abciximab combination therapy in the porcine myocardial infarction model. Thromb Res. 2012 Aug;130(2):265–272.
98. M.Sezer, A.Cimen, E.Aslanger, et al. Effect of intracoronary streptokinase administered immediately after primary percutaneous coronary intervention on long-term left ventricular infarct size, volumes, and function. J Am Coll Cardiol. 2009 Sep 15;54(12):1065–1071.
99. M.Sezer, H.Oflaz, T.Gören, et al. Intracoronary streptokinase after primary percutaneous coronary intervention. N Engl J Med. 2007 May 3;356(18):1823–1834.
100. A.M.Sprinkart, J.A.Luetkens, F.Träber, et al. Gradient Spin Echo (GraSE) imaging for fast myocardial T2 mapping. J Cardiovasc Magn Reson. 2015 Feb 12;17(1):12–19.
101. H.-J.Yang, J.Pang, B.Sharif, et al. Fast, whole-heart, free-breathing 3D T2 mapping at 3T with application to myocardial edema imaging. J Cardiovasc Magn Reson. 2015;17(1):1–2.
102. T.Hagio, C.Huang, A.Abidov, et al. T2 mapping of the heart with a double-inversion radial fast spin-echo method with indirect echo compensation. J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson. 2015;17:24.
103. D.O.h-Ici, S.Jeuthe, N.Al-Wakeel, et al. T1 mapping in ischaemic heart disease. Eur Heart J Cardiovasc Imaging. 2014 Jun 1;15(6):597–602.
104. D.Carrick, K.G.Oldroyd, M.McEntegart, et al. A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI). J Am Coll Cardiol. 2014 May 27;63(20):2088–2098.
105. P.Kellman, H.Xue, B.S.Spottiswoode, et al. Free-breathing T2* mapping using respiratory motion corrected averaging. J Cardiovasc Magn Reson. 2015 Jan 24;17(1):3.